Fetal hemoglobin (HbF) has potential to improve sickle cell disease by impacting pathophysiology, clinical course, and curative therapy.This article discusses HbF quantitative trait loci, ?-globin gene haplotypes in the Middle East, and the effects of HbF on sickle cell disease.